On 10 November, Oura agreed to pay $625 million in cash for Counsel Health, a primary care company with about 70 employees [1][2].
Six days later the chief executive of Noom, which sells weight-loss programmes to employers and health plans, said wearables “are a commodity and should effectively be given away”. Then he announced one that his clients will get for free [3].
One company earns most of its money selling a $399 ring and has just bought doctors. The other sells care and has just built a device to give away. They are assembling the same product from opposite ends, and where they meet shows which part of it will be worth money.
What did Oura buy for $625 million?
A way to turn a reading on a ring into a doctor’s answer. Counsel pairs a medical AI with its own physicians. A member starts in a chat and can add a board-certified doctor to the same conversation, who can diagnose, prescribe and refer [1]. On its own site Counsel charges $29 per visit or $300 a year [4].
The two companies already work together. Counsel has been inside the Oura app since 8 June, as a $159-a-year plan of which $76.50 goes to Counsel’s medical group [5]. Oura says more than half of the people who reached Counsel through its app chose to share their ring data with the physician [6].
| The deal | Detail |
|---|---|
| Price | $625 million in cash, subject to adjustments [1] |
| Expected to close | Before the end of 2026 [1] |
| Counsel | About 70 employees; raised a $25 million Series A a year ago, led by Andreessen Horowitz and GV [2] |
| Oura | More than 6 million members; fiscal 2026 revenue of about $1.75 billion, up 92% (preliminary and unaudited) [1] |
| After the deal | Counsel keeps selling to health plans, health systems and employers [1] |
Is Oura the only wearable company adding doctors?
No, and it was not the first.
WHOOP set up its own physician group instead of buying one. It announced video visits with clinicians inside its app in May [7]. In August it launched Connected Care, a programme for Medicare patients with conditions such as hypertension, delivered by an affiliated physician group, WHOOP Physician Services [8]. Participants get a 12-month membership and a blood pressure cuff at no out-of-pocket cost [8].
Noom came from the other side. It already had clinicians, prescriptions and a home test kit. What it lacked was continuous data from the body. Fewer than 10% of its members own an Oura Ring, a WHOOP or a newer Fitbit, its chief executive told Fierce Healthcare [3]. The Noom Band, built on hardware from a company called Sensor Bio, goes to employer and health plan clients from early 2027 at no added upfront cost [3].
Apple and Google sell the sensor, the blood test and the guidance, and have announced no clinicians of their own. We looked at why when Google added Function Labs.
Why would a hardware company buy doctors while a care company gives hardware away?
Because of who pays, and for what.
Consumers pay for the device and then do little with the data. About four-fifths of Oura’s revenue is still hardware, as we set out in our reading of its IPO filing. In a survey published this month by Andreessen Horowitz, 55% of wearable users said their data had never prompted a behaviour change or a doctor’s visit [9]. A doctor in the app is the missing next step, and a reason to keep paying. Oura describes the goal as a “24-7 doctor in your pocket” [1].
Payers pay for results, and not very much. Medicare’s ACCESS model pays organisations to manage patients with chronic conditions. WHOOP has joined it, Counsel joins in early 2027 using Oura data, and Noom plans to [8][10][3]. In its early cardio-kidney-metabolic track the model pays $360 per patient per year, and half of that is held back until outcomes are checked [11].
That comparison is ours, and list price is not what a device costs to make. But it shows the direction. Where a health plan or Medicare is paying, the device has to be cheap or free, and the money is in the care and the result. Noom’s chief executive said he is paid on outcomes and expects more members to hit their weight-loss targets with a band than without one [3].
A caution on Noom’s evidence. Its headline figure, that members on a GLP-1 drug who used a connected wearable were 34% more likely to lose 20 pounds by their fourth month, comes from the company’s own analysis of 144,000 members [3]. It compares people who connected any wearable with people who did not. Those groups may differ in other ways, so it does not show that a band causes the difference.
What changes if your product is built on wearable data?
Three things.
1. Your data supplier may become your competitor. Oura’s developer agreement says you may not build anything that “competes with or merely replicates those of Oura” [12]. It took effect on 8 June 2026, the same day Counsel’s doctors went live in the Oura app [5][12]. When that sentence was written, Oura’s own products were a ring, an app and blood panels. After this deal they include primary care, prescriptions and weight management. We are not saying Oura will enforce the clause against any particular app. We are saying the clause is broad and Oura’s product just got broader. The same agreement limits what data aggregators can pass to AI models, which we compared across providers in our guide to API rules on AI.
2. Every company wants to own the interpretation. Noom built its own band instead of partnering because it did not want a partner’s app competing with Noom’s to interpret the signal, its chief executive said [3]. Apple and Google keep the interpretation in their own apps too. The sensor is becoming a commodity. What each company guards is the reading of it.
3. Most of your users will not have the device. If fewer than 10% of the people in a weight-loss programme own a premium wearable, a product that needs one reaches a tenth of them. Among Americans over 65, 78% own a smartphone and 23% have used a wearable for health, as we covered in wearables and adults over 65. Design for the phone first and any wearable second.
Employers and health plans have a fourth thing to check: who else pays the vendor. Eli Lilly’s pharmacy platform already sends people seeking weight-loss drugs to Counsel, whose doctors can prescribe Lilly’s Zepbound and Foundayo [13]. Lilly has also agreed to buy $50 million of Oura stock if certain conditions are met, which it says has not happened yet [14]. Once Oura owns Counsel, a drugmaker could hold a stake in the company whose doctors prescribe its drugs. That is not improper in itself. It is the kind of tie a buyer should ask about.
What should health apps, care programmes and employers do now?
- Health and wellness apps. Do not rest a core feature on one device maker’s cloud API. Read the terms for competition and AI clauses before you build. Where you can, read data the user holds on their phone through Apple Health and Health Connect, where access depends on the user’s permission.
- Care programmes and digital health companies. Accept the phone and any wearable a member already owns. Noom’s answer to the 10% problem was to build a band. Most programmes can get sleep, activity and heart rate signals from what members already carry. Treat a device as a cost of delivering the outcome, not as a product to sell.
- Employers and health plans. Ask every vendor three questions. Who employs the clinicians? What happens to a member’s data and device if we end the contract? Who else pays you?
In one week a device maker paid $625 million for doctors and a care company priced a device at zero. Both moves say the same thing: the sensor is the cheap part. The value is in data that reaches someone who can act on it, and in proving that acting on it worked.
References
- Counsel Health. (2026). Oura to acquire Counsel Health, advancing vision for more connected, personalized healthcare. 10 November 2026. https://www.counselhealth.com/newsroom/oura-to-acquire-counsel-health-advancing-vision-for-more-connected-personalized-healthcare
- TechCrunch. (2026). Oura to acquire AI-native primary care startup Counsel Health for $625M. 10 November 2026. https://techcrunch.com/2026/11/10/oura-to-acquire-ai-native-primary-care-startup-counsel-health-for-625m/
- Landi, H. (2026). HLTH 2026: Noom pushes deeper into connected health with new wearable, Noom Band. Fierce Healthcare, 16 November 2026. https://www.fiercehealthcare.com/health-tech/hlth26-noom-expands-metabolic-health-strategy-new-wearable-noom-band
- Counsel Health. Pricing shown on the home page: $29 per 7-day visit or $300 a year. Retrieved 18 November 2026. https://www.counselhealth.com/
- Oura. (2026). Counsel integration in the Oura App. Published 8 June 2026, updated 19 October 2026. https://ouraring.com/blog/counsel-integration-oura-app/
- Oura. (2026). Oura announces agreement to acquire Counsel Health, the AI-native, physician-supervised care platform. 10 November 2026. https://ouraring.com/blog/oura-to-acquire-counsel-health/
- Vaidya, A. (2026). Whoop adds telehealth, AI features to wearable fitness tracker. TechTarget, 12 May 2026. https://www.techtarget.com/virtualhealthcare/news/366643016/Whoop-adds-telehealth-AI-features-to-wearable-fitness-tracker
- WHOOP. (2026). WHOOP launches Connected Care to help eligible Medicare beneficiaries better understand their health. 12 August 2026. https://www.whoop.com/us/en/press-center/whoop-launches-connected-care-to-help-eligible-medicare-beneficiaries-better-understand-their-health/
- Wolf, D., and Steinman, E. (2026). The State of Longevity. Andreessen Horowitz, 3 November 2026. https://a16z.com/the-state-of-longevity/
- Oura. (2026). Oura and Counsel in the CMS ACCESS Model. 17 September 2026. https://ouraring.com/blog/cms-access-model/
- CMS Innovation Center. ACCESS Model: Model Payment Amounts and Performance Targets, Effective Period 5 July 2026 to 31 December 2027. https://www.cms.gov/priorities/innovation/files/access-payments-amts-perf-targets.pdf
- Oura. Oura API and MCP Agreement. Effective 8 June 2026. Retrieved 18 November 2026. https://cloud.ouraring.com/legal/api-agreement
- Gleeson, C. (2026). Counsel Health launches AI-native weight management program, inks partnership with Lilly Direct. Fierce Healthcare, 28 October 2026. https://www.fiercehealthcare.com/digital-health/counsel-health-launches-weight-management-program-collabs-eli-lillys-lillydirect
- Keshavan, M. (2026). Oura deal may complicate Lilly’s GLP-1 telehealth ties. STAT, The Readout, 13 November 2026. https://www.statnews.com/2026/11/13/biotech-news-hhs-funding-for-research-into-ibogaine-for-ptsd/
- Sahha. Scores. Sahha Docs. https://sahha.ai/docs/products/scores/
- Sahha. Biomarkers. Sahha Docs. https://sahha.ai/docs/products/biomarkers/